AMEX · Medical - Devices

ELMD (ELMD) Stock

$39.48 -0.95% AMEX: ELMD Healthcare

Valuation

MetricValue
Price$39.48
Market Cap$326.90M
P/E Ratio32.25
P/B Ratio6.35
P/S Ratio4.35
EPS (TTM)$1.03
52-Week High$47.23
52-Week Low$17.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE21.70%
ROA14.86%
ROCE23.26%
Gross Margin78.44%
Operating Margin18.55%
Net Margin14.08%
Debt/Equity0.00
Current Ratio4.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$36.0M$42.0M$48.0M$55.0M$64.0M
Operating Profit$3.0M$3.0M$4.0M$7.0M$10.0M
Net Profit$2.0M$2.0M$3.0M$5.0M$8.0M
EPS$0.27$0.26$0.36$0.58$0.86
Op Margin8.8%7.1%8.3%12.0%15.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$37.0M$41.0M$46.0M$52.0M$54.0M
Total Liabilities$5.0M$7.0M$8.0M$8.0M$11.0M
Cash$12.0M$8.0M$7.0M$16.0M$15.0M
Borrowings$0$0$0$0$0

Latest News

4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX Zacks · Jul 10, 2026 Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why Zacks · Jul 6, 2026 ELV Accelerates Clinical Reviews Through Health OS Platform Zacks · Jun 24, 2026 Here's Why Momentum in Electromed (ELMD) Should Keep going Zacks · Jun 19, 2026 Electromed Insider Sold Shares Worth $354,095, According to a Recent SEC Filing MT Newswires · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.0M$-1.0M$1.0M$9.0M$11.0M
Investing Cash Flow$-1.0M$-3.0M$-3.0M$-1.0M$-1.0M
Financing Cash Flow$-1.0M$-2.0M$0$0$-12.0M
Net Cash Flow$1.0M$-4.0M$-1.0M$9.0M$-1.0M
Free Cash Flow$3.0M$-2.0M$0$9.0M$11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.35
EV / EBITDA20.03
FCF Yield3.27%
Quick Ratio4.59
Interest Coverage—
Return 1Y100.31%
Return 3Y244.27%
Return 5Y273.86%

Ownership

Insiders Held17.18%
Institutions Held58.33%
Institutions Float Held70.43%
Institutional HolderSharesReport Date
J.e. Simmons & Co., P.c.492,8222026-03-31
Blackrock Inc.458,8452026-03-31
Vanguard Capital Management LLC335,0282026-03-31
Punch & Associates Investment Management, Inc.224,5202026-03-31
Acadian Asset Management. LLC222,7552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
INFU $9.92 +5.98% 32.90 $200.20M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%

About ELMD

ELMD is led by CEO James L. Cunniff, employs 174 people, headquartered in US, publicly traded since 2010.

ELMD stock trades at $39.48 with a market capitalization of $326.90M. The stock is valued at a price-to-earnings (P/E) ratio of 32.25, price-to-book of 6.35, price-to-sales of 4.35. Over the past 52 weeks the stock has ranged between $17.73 and $47.23, and currently trades 16.4% below its 52-week high.

On profitability, ELMD generates a return on equity (ROE) of 21.70% — well above the market average, a sign of a high-quality business, return on capital employed of 23.26%, an operating margin of 18.55%, a net profit margin of 14.08%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides